Dr. Moore on Immunotherapy and PARP Combinations in BRCA-Mutated Ovarian Cancer – OncLive
OncLive |
Dr. Moore on Immunotherapy and PARP Combinations in BRCA-Mutated Ovarian Cancer
OncLive Kathleen N. Moore, MD, assistant professor, The Stephenson Cancer Center, The University of Oklahoma, discusses combinations of immunotherapy with PARP inhibitors for patients with BRCA-mutated ovarian cancer. There is evidence for combining PARP … |
